Home > Drug Search >
  • Targets: Microsomal prostaglandin E2 synthase 1 (mPGES-1)
  •   > 
Drug Filter
Category:
chemistry (22) biology (6)
Status:
Approved (7) NDA Filing (1) Phase Ⅲ (6) Phase Ⅱ (6) Phase Ⅰ (8)
Clinical Stage:
Pending (2) Active (12) Discontinued (7)
Bio-Type:
Recombinant polypeptide (4) Recombinant cytokines (1) Fusion protein (1)
Company:
Daiichi Sankyo (2) Ferring Pharmaceuticals (1) GlaxoSmithKline (1) Helsinn (1) IL-Yang (1) Johnson & Johnson (1) Millennium Pharmaceutical (1) Nippon Shinyaku Pharma (1) Novartis (1) Nycomed Pharmaceutical (1) Palatin Technologies (1) Pfizer (2) Sanofi (2) Shire (1) Taiho Pharma (1) Takeda (2) Innovent Biologics (1) GLyPharma (1) Glenmark Pharma (1) Zealand Pharma (1) Adocia (1) Tyrogenex (1) AnewPharma (1) Zelgen Biosciences (1) M.D. Anderson Cancer Center (1) Global Neurotech (1) Toyota Tsusho (1) 成都诺迪康生物 (1) AB Science (1) Amgen (1) Ariad (1) Bayer (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (2) Acute myeloid Leukemia (AML) (1) Acutely decompensated congestive heart failure (ADHF) (1) Advanced non-squamous non small cell lung cancer (NSCLC) (1) Alzheimer's disease (AD) (1) Amyotrophic lateral sclerosis (ALS) (1) Arthritis (1) Chemotherapy-induced nausea and vomiting (1) Chronic myeloid leukemia (CML ) (4) Colorectal neoplasms (1) Depression (1) Diabetic macular edema (1) Diarrhea (1) Differentiated thyroid cancer (1) Endometriosis (1) Gastrointestinal stromal tumors (GISTs) (2) Pancreatitis (1) Heart failure (2) Hepatocellular carcinoma (HCC) (2) Melanoma (1) Multiple myeloma (MM) (1) Myelodysplastic syndrome (MDS) (2) Ovarian cancer (1) Pancreatic cancer (1) Parkinson's disease (PD) (1) Pathologic myopia (1) Postoperative nausea and vomiting (1) Prostate cancer (1) Solid tumours (4) Myeloproliferative Disorders (MPD) (1) Aggressive systemic mastocytosis (ASM) (1) Hypereosinophilic syndrome (HES) (1) Dermatofibrosarcoma protuberans (DFSP) (1) Chronic eosinophilic leukemia (CEL) (1) Colon cancer (1) Diabetic foot ulcers (1) Age-related macular degeneration (AMD) (5) Pain (1) Macular edema (1) Diabetes (1) Renal carcinoma (1) Short bowel syndrom (1) Acute heart failure (1) Gastrointestinal disorders (1) Inflammation (1)
Country:
US (2) JP (1) CN (1) KR (1)
Aprv. Year:
 (2) 1995 (1) 2001 (1) 2005 (1) 2012 (2)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top